Sinapic acid is found in many edible plants and fruits, such as rapeseed, where it is the predominant phenolic compound. New sinapic acid phenethyl ester (SAPE) analogues were synthesized and screened as inhibitors of the biosynthesis of 5-lipoxygenase (5-LO) in stimulated HEK293 cells and polymorphonuclear leukocytes (PMNL). Inhibition of leukotriene biosynthesis catalyzed by 5-LO is a validated therapeutic strategy against certain inflammatory diseases and allergies. Unfortunately, the only inhibitor approved to date has limited clinical use because of its poor pharmacokinetic profile and liver toxicity. With the new analogues synthesized in this study, the role of the phenolic moiety, ester function, and bioisosterism was investigated. Several of the 34 compounds inhibited the biosynthesis of 5-LO products, and 20 compounds were 2-11 times more potent than zileuton in PMNL, which are important producers of 5-LO products. Compounds <b>5i</b> (IC<sub>50</sub>: 0.20 μM), <b>5l</b> (IC<sub>50</sub>: 0.20 μM), and <b>5o</b> (IC<sub>50</sub>: 0.21 μM) bearing 4-trifluoromethyl, methyl, or methoxy substituent at <i>meta</i>-position of the phenethyl moiety were 1.5 and 11.5 times more potent than SAPE (IC<sub>50</sub>: 0.30 μM) and zileuton (IC<sub>50</sub>: 2.31 μM), respectively. Additionally, compound <b>9</b> (IC<sub>50</sub>: 0.27 μM), which was obtained after acetylation of the 4-hydroxyl of SAPE, was equivalent to SAPE and 8 times more active than zileuton. Furthermore, compound <b>20b</b> (IC<sub>50</sub>: 0.27 μM) obtained after the bioisosteric replacement of the ester function of SAPE by the 1,2,4-oxadiazole heterocycle was equivalent to SAPE and 8 times more active than zileuton. Thus, this study provides a basis for the rational design of new molecules that could be developed further as anti 5-LO therapeutics.